Position in AKTS
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$319,334
New position
Shares Held
9,908
first reported quarter
Ownership
0.018%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#67
of 114 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Caprock Group, LLC holds $30,859,861 across 35 Biotechnology names. AKTS ranks #16 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
33,721 | $16,750,232 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
8,663 | $2,087,523 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,437 | $1,519,566 | |
| 4 | ARGX |
Argenx SE
|
1,543 | $1,431,549 | |
| 5 | TWST |
Twist Bioscience Corp
|
8,447 | $869,027 | |
| 6 | AUPH |
Aurinia Pharmaceuticals Inc.
|
44,542 | $755,877 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
3,115 | $583,377 | |
| 8 | MRNA |
Moderna, Inc.
|
7,765 | $543,782 |
All Filings in AKTS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $319,334 | 9,908 | Shares | Sole | 2026-07-27 | |
| No filing history on record for this holder in this stock. | ||||||